Vatanparast Mahboubeh, Khalili Mohammad Ali, Yari Nahid, Woodward Bryan, Mohsenzadeh Mehdi
Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Yazd Reproductive Sciences Institute, Shahid Sadoughi Medical Sciences University, Yazd, Iran.
Arch Gynecol Obstet. 2018 Sep;298(3):607-615. doi: 10.1007/s00404-018-4838-x. Epub 2018 Jul 12.
Ovarian tissue (OT) cryopreservation is a treatment option for fertility preservation among young cancer patients. However, the procedure may involve a reduction in the GDF9-β expression and a delay in follicular growth after thawing and transplantation. The aim of this study was to evaluate whether supplementation of GDF9-β can compensate the reduction of this factor during the cryopresevation process and promote folliculogenesis after transplantation of thawed sheep ovarian tissue.
Sheep OT was cryopreserved using two methods of vitrification and slow freezing. Fresh and thawed OTs were then transplanted onto chick embryo chorioallantoic membrane (CAM) and then divided into two groups based on the addition of GDF9-β to the grafted tissue. After 5 days of culture, both histological and immunohistological (Ki-67) assessments were performed to evaluate follicular structure, development, and proliferation. The fibrotic and necrotic areas were measured using MICROVISIBLE software.
Folliculogenesis took place in all culture groups, but was significantly improved only in the +GDF9-β cultured group. Also, better follicular structure was preserved in the aforementioned group (p < 0.05). When GDF9-β was supplemented to the culture medium, more neovascularization (p < 0.05) and better transplantation (p > 0.05) was observed. Furthermore, the areas of fibrosis and necrosis were lower in this group rather than the controls. Follicular proliferative activity was significantly higher only in the slow freezing +GDF9-β cultured group.
GDF9-β, as a stimulatory factor, not only promoted the folliculogenesis in the fresh ovarian transplant, but also compensated for its reduction during the cryopreservation process.
卵巢组织(OT)冷冻保存是年轻癌症患者生育力保存的一种治疗选择。然而,该过程可能会导致解冻和移植后生长分化因子9β(GDF9-β)表达降低以及卵泡生长延迟。本研究的目的是评估补充GDF9-β是否可以弥补冷冻保存过程中该因子的减少,并促进解冻后的绵羊卵巢组织移植后的卵泡发生。
采用玻璃化冷冻和慢速冷冻两种方法对绵羊OT进行冷冻保存。然后将新鲜和解冻后的OT移植到鸡胚尿囊膜(CAM)上,并根据移植组织中是否添加GDF9-β分为两组。培养5天后,进行组织学和免疫组织化学(Ki-67)评估,以评估卵泡结构、发育和增殖情况。使用MICROVISIBLE软件测量纤维化和坏死区域。
所有培养组均发生了卵泡发生,但仅在+GDF9-β培养组中显著改善。此外,上述组中卵泡结构保存更好(p<0.05)。当在培养基中补充GDF9-β时,观察到更多的新生血管形成(p<0.05)和更好的移植效果(p>0.05)。此外,该组的纤维化和坏死区域低于对照组。仅在慢速冷冻+GDF9-β培养组中卵泡增殖活性显著更高。
GDF9-β作为一种刺激因子,不仅促进了新鲜卵巢移植中的卵泡发生,还弥补了冷冻保存过程中其表达的降低。